Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Transfemoral port-catheter system withdrawal complications are assessed
September 20th, 2006
The feasibility and safety of the withdrawal procedure for percutaneous transfemorally implanted port-catheter systems are studied. According to a study from Japan, "Our purpose is to evaluate the feasibility and safety of the withdrawal procedure of percutaneous transfemorally implanted port-catheter systems. Thirty-seven patients (17.7%) underwent the withdrawal procedure of this port-catheter system among 209 patients." Y. Yahiro and colleagues, Hiroshima University, wrote, "The reasons for withdrawal were as follows: termination of intra-arterial chemotherapy (n=7), obstruction of hepatic artery (n=5), port infection (n=4), catheter infection...
Source: Biotech Week (2006-09-20)
|
